Clinical Trials

The following is a list of clinical trials which are currently open for subject enrollment at the University of Rochester Medical Center. In addition, there are many more trials in the process of being opened.

For general information about Neuroocology clinical trials or to find out what is coming in the future, please contact Research Associate, Jennifer Serventi, RPA-C at 585-275-5863.

For information about one of the trials below, please see the contact info for each specific trial.

Current Clinical Trials
RTOG 0574: A study of the role of whole brain irradiation plus radiosurgery for brain metastases
RTOG 0625:Study using Bevacizumab with Irinotecan or Bevacizumab with Temozolomide in treating Recurrent GBM
RTOG 0320: A Study of Patients with Brain Metastases from Non-Small Cell Lung Cancer being treated with Whole Brain Radiation Therapy and Radiosurgery with or without Chemotherapy
RTOG 0513: A Study Adding an Investigational Drug to Standard Care for Treatment of Newly Diagnosed Glioblastoma Multiforme
RTOG 0614: Brain Metastases study testing Investigational drug versus Placebo for Prevention of Cognitive Problems from Whole Brain Radiation Therapy
Accelerated Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma Multiforme – a Pilot Study
A Phase 1/2 Dose Escalatian Study of Locally-Administered OncoGel in Subjects with Recurrent Glioma
A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regiment for High Risk Low-Grade Gliomas
Pilot Study of Resection Combind with Stereotactic Radiosurgery in Patients with Limited (1-3) Brain Metastases